Fyn酪氨酸激酶作为受体酪氨酸激酶下游靶点调节抗胶质瘤免疫反应
研究利用基因工程小鼠胶质瘤模型及Fyn敲低干细胞,在免疫健全与免疫缺陷小鼠中观察Fyn对胶质瘤生长和免疫微环境的影响。结果显示免疫健全小鼠中Fyn敲低抑制肿瘤进展并延长生存,而免疫缺陷小鼠中无生存差异,提示Fyn通过减少免疫抑制性髓系细胞增强免疫抑制。作者提出抑制胶质瘤细胞内的Fyn可能提高抗胶质瘤免疫治疗疗效。
要点
- 免疫健全基因工程小鼠胶质瘤模型中Fyn敲低减少肿瘤进展并显著延长生存。
- NSG、CD8-/-和CD4-/-免疫缺陷小鼠中Fyn敲低胶质瘤未见生存差异。
- 流式细胞术显示Fyn敲低胶质瘤微环境中免疫抑制性髓系来源细胞数量和活性降低。
核心结论
- 胶质瘤利用Fyn介导的机制增强免疫抑制并促进肿瘤进展。
- 作者提出抑制胶质瘤细胞内的Fyn可能提高抗胶质瘤免疫治疗的疗效。
研究设计与样本
- 研究使用基因工程小鼠胶质瘤模型(GEMMs)评估Fyn的作用。
- 研究还生成Fyn敲低干细胞,在免疫健全和免疫缺陷小鼠(非肥胖糖尿病重症联合免疫缺陷gamma小鼠[NSG]、CD8-/-、CD4-/-)中诱导胶质瘤。
- 研究通过RNA测序和生物信息学分析分析分子机制,并用流式细胞术表征Fyn敲低胶质瘤微环境中的免疫细胞浸润。
主要发现
- 在多种免疫健全GEMMs中,Fyn敲低减少肿瘤进展并显著增加生存。
- 对野生型与Fyn敲低胶质瘤差异表达基因的基因本体(GO)分析显示,与免疫反应性相关的GO富集。
- 在NSG、CD8-/-和CD4-/-免疫缺陷小鼠中,Fyn敲低胶质瘤未显示生存差异。
- 流式细胞术检查显示,Fyn胶质瘤微环境中免疫抑制性髓系来源细胞的量和活性降低。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: High-grade gliomas are aggressive and immunosuppressive brain tumors. Molecular mechanisms that regulate the inhibitory immune tumor microenvironment (TME) and glioma progression remain poorly understood. Fyn tyrosine kinase is a downstream target of the oncogenic receptor tyrosine kinase pathway and is overexpressed in human gliomas. Fyn's role in vivo in glioma growth remains unknown. We investigated whether Fyn regulates glioma initiation, growth and invasion. METHODS: We evaluated the role of Fyn using genetically engineered mouse glioma models (GEMMs). We also generated Fyn knockdown stem cells to induce gliomas in immune-competent and immune-deficient mice (nonobese diabetic severe combined immunodeficient gamma mice [NSG], CD8-/-, CD4-/-). We analyzed molecular mechanism by RNA sequencing and bioinformatics analysis. Flow cytometry was used to characterize immune cellular infiltrates in the Fyn knockdown glioma TME. RESULTS: We demonstrate that Fyn knockdown in diverse immune-competent GEMMs of glioma reduced tumor progression and significantly increased survival. Gene ontology (GO) analysis of differentially expressed genes in wild-type versus Fyn knockdown gliomas showed enrichment of GOs related to immune reactivity. However, in NSG and CD8-/- and CD4-/- immune-deficient mice, Fyn knockdown gliomas failed to show differences in survival. These data suggest that the expression of Fyn in glioma cells reduces antiglioma immune activation. Examination of glioma immune infiltrates by flow cytometry displayed reduction in the amount and activity of immune suppressive myeloid derived cells in the Fyn glioma TME. CONCLUSIONS: Gliomas employ Fyn mediated mechanisms to enhance immune suppression and promote tumor progression. We propose that Fyn inhibition within glioma cells could improve the efficacy of antiglioma immunotherapies.
引用
- Comba A, Dunn PJ, Argento AE, et al. Fyn tyrosine kinase, a downstream target of receptor tyrosine kinases, modulates antiglioma immune responses. Neuro Oncol. 2020. PMID: 31950181. doi:10.1093/neuonc/noaa006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。